Eden Research plc (EDNSF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.04 Million GBP | 40.59% |
| 2022 | 2.16 Million GBP | -1.32% |
| 2021 | 2.19 Million GBP | 10.13% |
| 2020 | 1.99 Million GBP | 31.53% |
| 2019 | 1.51 Million GBP | 60.9% |
| 2018 | 942.86 Thousand GBP | -54.49% |
| 2017 | 2.07 Million GBP | 100.63% |
| 2016 | 1.03 Million GBP | 37.23% |
| 2015 | 752.55 Thousand GBP | 64.2% |
| 2014 | 458.3 Thousand GBP | -46.34% |
| 2013 | 854.09 Thousand GBP | -59.22% |
| 2012 | 2.09 Million GBP | -27.97% |
| 2011 | 2.9 Million GBP | -48.77% |
| 2010 | 5.67 Million GBP | 37.8% |
| 2009 | 4.11 Million GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 3.04 Million GBP | 40.59% |
| 2023 Q4 | 3.04 Million GBP | 0.0% |
| 2023 Q1 | 2.1 Million GBP | -2.93% |
| 2023 Q2 | 2.1 Million GBP | 0.0% |
| 2023 Q3 | 3.04 Million GBP | 44.83% |
| 2022 FY | 2.16 Million GBP | -1.32% |
| 2022 Q4 | 2.16 Million GBP | 0.0% |
| 2022 Q3 | 2.16 Million GBP | 8.37% |
| 2022 Q2 | 2 Million GBP | 0.0% |
| 2022 Q1 | 2 Million GBP | -8.94% |
| 2021 Q1 | 2.51 Million GBP | 26.04% |
| 2021 FY | 2.19 Million GBP | 10.13% |
| 2021 Q2 | 2.22 Million GBP | -11.34% |
| 2021 Q4 | 2.19 Million GBP | 0.0% |
| 2021 Q3 | 2.19 Million GBP | -1.45% |
| 2020 Q4 | 1.99 Million GBP | 0.0% |
| 2020 Q1 | 1.15 Million GBP | -24.0% |
| 2020 Q2 | 1.56 Million GBP | 35.47% |
| 2020 FY | 1.99 Million GBP | 31.53% |
| 2020 Q3 | 1.99 Million GBP | 27.75% |
| 2019 Q2 | 741 Thousand GBP | 9.94% |
| 2019 Q4 | 1.51 Million GBP | 0.0% |
| 2019 Q3 | 1.51 Million GBP | 104.74% |
| 2019 FY | 1.51 Million GBP | 60.9% |
| 2019 Q1 | 674 Thousand GBP | -28.52% |
| 2018 FY | 942.86 Thousand GBP | -54.49% |
| 2018 Q2 | 1.11 Million GBP | 6.39% |
| 2018 Q4 | 942.86 Thousand GBP | 7.71% |
| 2018 Q3 | 875.4 Thousand GBP | -21.56% |
| 2018 Q1 | 1.04 Million GBP | -49.37% |
| 2017 Q4 | 2.07 Million GBP | 3.37% |
| 2017 Q3 | 2 Million GBP | 69.73% |
| 2017 Q2 | 1.18 Million GBP | 6.01% |
| 2017 Q1 | 1.11 Million GBP | 7.87% |
| 2017 FY | 2.07 Million GBP | 100.63% |
| 2016 FY | 1.03 Million GBP | 37.23% |
| 2016 Q4 | 1.03 Million GBP | 6.99% |
| 2016 Q2 | 598 Thousand GBP | 0.0% |
| 2016 Q3 | 965.28 Thousand GBP | 61.42% |
| 2016 Q1 | 598 Thousand GBP | -20.54% |
| 2015 Q2 | 428 Thousand GBP | 0.0% |
| 2015 Q4 | 752.55 Thousand GBP | 0.0% |
| 2015 Q3 | 752.55 Thousand GBP | 75.83% |
| 2015 Q1 | 428 Thousand GBP | -6.61% |
| 2015 FY | 752.55 Thousand GBP | 64.2% |
| 2014 Q2 | 1.82 Million GBP | 0.0% |
| 2014 Q1 | 1.82 Million GBP | 113.09% |
| 2014 FY | 458.3 Thousand GBP | -46.34% |
| 2014 Q4 | 458.3 Thousand GBP | -0.0% |
| 2014 Q3 | 458.3 Thousand GBP | -74.82% |
| 2013 Q3 | 854.09 Thousand GBP | 347.17% |
| 2013 Q1 | 191 Thousand GBP | -90.88% |
| 2013 Q2 | 191 Thousand GBP | 0.0% |
| 2013 FY | 854.09 Thousand GBP | -59.22% |
| 2013 Q4 | 854.09 Thousand GBP | 0.0% |
| 2012 FY | 2.09 Million GBP | -27.97% |
| 2012 Q4 | 2.09 Million GBP | 0.0% |
| 2012 Q2 | 1.89 Million GBP | 0.0% |
| 2011 FY | 2.9 Million GBP | -48.77% |
| 2010 FY | 5.67 Million GBP | 37.8% |
| 2009 FY | 4.11 Million GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Allied Energy Corporation | 4.34 Million USD | 29.865% |
| Earth Alive Clean Technologies Inc. | 994.33 Thousand USD | -206.629% |
| Igene Biotechnology, Inc. | 7.5 Million USD | 59.36% |
| Lotus Bio-Technology Development Corp. | - USD | -Infinity% |
| MagIndustries Corp. | 99.83 Million USD | 96.946% |
| Itafos Inc. | 346.68 Million USD | 99.121% |
| Potash America, Inc. | 2.33 Million USD | -30.766% |
| Yara International ASA | 8.45 Billion USD | 99.964% |
| Yara International ASA | 8.43 Billion USD | 99.964% |